These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 1001603)
1. [After miniaturization to the limit, a double phase estro-progestin with early reinforcement. Result of a study of a new contraceptive based on d-norgestrel]. Soutoul JH; Renaud M; Bertrand J Gynecologie; 1976; 27(5):487-93. PubMed ID: 1001603 [No Abstract] [Full Text] [Related]
2. [Clinical studies on the low-dosage norgestrel-ethinylestradiol combination as a long term oral contraception (author's transl)]. Higashiyama S; Obata T; Kizu S; Nakano Y; Iwasaki T Nihon Funin Gakkai Zasshi; 1974 Jan; 19(1):40-53. PubMed ID: 4478810 [No Abstract] [Full Text] [Related]
4. [Changes in vaginal cytograms of female beagle dogs during toxicologic long-term examinations of gestagens]. Strecke J; Oettel M; Hillesheim HG; Hoffmann H Z Versuchstierkd; 1982; 24(3):117-25. PubMed ID: 6814094 [No Abstract] [Full Text] [Related]
5. Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogen. Jespersen J; Kluft C Scand J Clin Lab Invest; 1982 Nov; 42(7):563-6. PubMed ID: 6818678 [TBL] [Abstract][Full Text] [Related]
6. [Effects, on the endometrium, of a new oral contraceptive: Physiostat]. Delacroix P Rev Fr Gynecol Obstet; 1977; 72(7-9):583-5. PubMed ID: 905717 [No Abstract] [Full Text] [Related]
7. Incidence of hyperprolactinemia during oral contraceptive therapy. Reyniak JV; Wenof M; Aubert JM; Stangel JJ Obstet Gynecol; 1980 Jan; 55(1):8-11. PubMed ID: 7352067 [TBL] [Abstract][Full Text] [Related]
8. Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel. Sabra A; Bonnar J J Reprod Med; 1983 Jan; 28(1 Suppl):85-91. PubMed ID: 6834350 [TBL] [Abstract][Full Text] [Related]
9. [Oral-cytological studies on the effect of combined contraceptive preparations as compared to menstruation and pregnancy]. Zellner P; Klinger G Stomatol DDR; 1982 Oct; 32(10):673-7. PubMed ID: 6190274 [No Abstract] [Full Text] [Related]
10. Central and peripheral parameters of the menstrual cycle under the influence of a new combined oral contraceptive. Spona J; Schneider WH Acta Obstet Gynecol Scand Suppl; 1976; 54():45-50. PubMed ID: 788444 [No Abstract] [Full Text] [Related]
11. [Some effects of hormonal contraceptives on the mammary tissue. Influence of duration of use and age os user]. de Sampaio Junior LF; Stecca J; Neme B Matern Infanc (Sao Paulo); 1974; 33(4):509-30. PubMed ID: 4470961 [No Abstract] [Full Text] [Related]
12. Norgestimate: overview of a monophasic formulation. Anderson FD; Gillmer MD Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():126-32. PubMed ID: 8260971 [No Abstract] [Full Text] [Related]
13. [Clinical studies on the SH 1000 as oral contraception (author's transl)]. Takayanagi M; Kamada M; Kushiki N; Lyo K; Fujiwara M Nihon Funin Gakkai Zasshi; 1974 Oct; 19(4):36-45. PubMed ID: 4478828 [No Abstract] [Full Text] [Related]
14. Effect of oral contraceptives on vitamin B6 nutriture of young women. Vir SC; Love AH Int J Vitam Nutr Res; 1980; 50(1):29-34. PubMed ID: 7390712 [TBL] [Abstract][Full Text] [Related]
15. Post coital contraception--A pilot study. Yuzpe AA; Thurlow HJ; Ramzy I; Leyshon JI J Reprod Med; 1974 Aug; 13(2):53-8. PubMed ID: 4844513 [TBL] [Abstract][Full Text] [Related]